Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, ...

Ultra-low-power analog signal processing circuits are essential for energy-constrained biomedical systems. This paper presents a novel gate-driven multiple-input operational transconductance amplifier ...

From targeting cancer cells to engineering 3D tissue, Michigan Tech's Biomedical Micro-Devices Lab operates at the intersection of biology and precision engineering. Just as cells are the building ...

With biomedical, IoT, and imaging systems becoming networked endpoints, many health systems lack the staffing models, inventory visibility, and governance needed to manage risk and maintain clinical ...

CEDAR PARK, Texas, June 11, 2025 (SEND2PRESS NEWSWIRE) — Zeteo Biomedical, a privately held biomedical device company, today announced the issuance of new patents in the United States and European ...

Orchestra BioMed has announced that the FDA has granted Breakthrough Device Designation for its atrioventricular interval modulation (AVIM) therapy, aimed at treating over 7.7 million U.S. patients ...

A Chinese-led team of scientists say they have developed a highly conductive 3D printing ink that can build circuits in hydrogel to create devices that can be used to monitor heart rate and stimulate ...

Orchestra BioMed Holdings' AVIM product received FDA breakthrough device designation, accelerating approval and offering speculative optimism for investors. The firm is pre-revenue with significant ...

Macrophage cells are the immune system’s frontline soldiers, early on the scene to protect the body from foreign invaders. These cells answer the immune system's critical question for the rest of its ...

Plants convert light into energy efficiently through photosynthesis—an ability that scientists and engineers still struggle to match with electronic devices. Recently, researchers have looked beyond ...